Evaluation of tumor necrosis factor-α, interleukin-6 and C-reactive protein plasma levels as predictors of bacteremia in patients presenting signs of sepsis without shock  by Byl, Baudouin et al.
ORIGINAL ARTICLE 
Evaluation of tumor necrosis factor-a, interleukin-6 
and C-reactive protein plasma levels as predictors of 
bacteremia in patients presenting signs of sepsis 
without shock 
Baudouin Byl‘, Jacques Devi&e’~~, Francis Saint-Hubert‘, Francis Zech4, 
Bkatrice Gulbis’ and Jean-Pierre Thys’ 
‘Infectious Diseases Clinic; 2Department of Immunology; 3Department of Gastroenterology, 
Erasme University Hospital, Brussels, Belgium; 41nfectious Diseases Clinic, Saint-Luc University 
Hospital, Brussels, Belgium; 5Clinical Chemistry, Erasme University Hospital, Brussels, Belgium 
Objective: To evaluate the sensitivity of interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) plasma measurement 
to  detect bacteremia in patients presenting sepsis signs, and to evaluate the potential benefit of such measurement in 
terms of early antimicrobial therapy initiation. 
Methods: Plasma was obtained from 166 hospitalized patients for whom blood cultures were drawn for sepsis. Clinical 
data and antimicrobial therapies were noted. IL-6, TNF and C-reactive protein (CRP) were measured. The sensitivities of 
these markers were retrospectively compared with the accuracy of the attending physician in  initiating empirical 
antimicrobial therapy. The setting was an 850-bed university hospital. 
Results: Thirty-four bacteremias and 69 non-bacteremic infections were noted. In 63 others, no infection was 
documented. Median (range) IL-6 plasma levels in the three groups of patients were 462 (15-50 850), 189 (<15-38 300) 
and 91 (<10-13 750) pg/mL, respectively (pc0.01). The corresponding TNF-a plasma levels were 37.5 (<15-2400), 15 
(~15-240) and 15 (45-200) pg/mL, respectively (pc0.01). CRP plasma levels were 10.7 (~0.6-30.2). 10.3 (~0.6-34.4) and 
7.3 (<0.6-20.9) mg/dL, respectively (p=0.12). With respect to these three parameters, IL-6 and TNF-a appear better than 
CRP for predicting bacteremia. Clinical features resulted in starting empirical antimicrobial therapy in only 62% of the 
bacteremic patients. On the other hand, 68% of these bacteremic patients had high IL-6 plasma levels (>200 pg/mL). A 
combination of clinical features and high IL-6 levels would have permitted early treatment for 82% of the bacteremic 
patients. 
Conclusions: IL-6 and TNF-a thus appear to be useful and earlier markers of bacteremia in septic patients. By contrast, 
CRP is neither sensitive nor specific in  this setting. 
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INTRODUCTION initiation of appropriate antimicrobial therapy has 
been shown to increase survival [1,2]. Therefore, 
Despite important medical progress, bacteremia remains early and accurate diagnosis of bacteremia is highly 
associated with high morbidity and mortality. Early desirable. However, as this diagnosis depends on 
positive blood cultures, the administration of appro- - _  
priate antimicrobial therapy is often delayed until these 
results are available. Several authors have tried to predict 
bacteremia using immediately available Parameters such 
as clinical signs and simple laboratory results, but the 
accuracy of such a diagnostic approach is poor [3-61. 
Because tumor necrosis factor-a (TNF-a) and inter- 
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presence of sepsis, we sought to deternine the sensi- 
tivity, specificity and predictive value of the plasma 
levels of these cytokines in the early detection of 
bacteremia in patients with suspicion of infection and 
compared these with clinical assessment and C-reactive 
protein (CRP) plasnia levels. 
MATERIALS AND METHODS 
Definitions 
Signs of sepsis were defined by any combination of two 
of the following signs: fever (>38.5 “C) or hypothermia 
(<35.6OC), tachypnea (respiratory rate >20 breaths/ 
min), tachycardia (heart rate >90 beatdmin), leuko- 
cytosis (>15 000/mm3) or leukopenia (<3000/nnn3), 
and abnormal neutrophil count (>70% of the white 
blood cell count). Septic shock was defined by hypo- 
tension (systolic blood pressure <90 mniHg) with 
diminished urine output and elevated lactate level 
(>2 nlEq/L), not due to hypovolemia or primary 
cardiac failure, requiring the administration of fluid and 
adrenergic drugs. 
Bacteremia was defined by the presence of at least 
two positive blood cultures for the same pathogen or 
one positive blood culture for a pathogen also isolated 
from another site. Infection was considered as proven if 
the criteria proposed by the Centers for Disease 
Control [7] were fulfilled. Initial severity scoring at the 
time when blood cultures were drawn was done using 
the Simplified Acute Physiology Score (SAPS) [8]. 
Clinical outcome was defined as unfavorable if 
septic shock or death related to infection occurred. 
Clinical outcome was considered as favorable if all the 
signs of sepsis disappeared. Death was considered to 
be related to infection if it occurred within the first 
7 days after the onset of infection or during a micro- 
biologically proven persisting infection. 
Patients 
During two consecutive months, all hospitalized patients 
from whom blood cultures were drawn for sepsis were 
eligible. Patients with septic shock, cirrhosis or previous 
antimicrobial therapy within the last 2 days were 
excluded. The following underlying diseases were 
noted: neoplasia (38 patients), solid organ trans- 
plantation (1 1), diabetes (16) and hemodialysis (8). 
According to the results of blood cultures and the 
presence of criteria of infection, patients were separated 
into three groups. The first group included the 
bacteremic patients. The second group included 
patients fulfilling criteria of infection but without 
positive blood cultures. The last group included 
patients in whom no infection was documented. For 
convenience, the patients constituting this last group 
were classified as ‘non-infected patients’. 
To evaluate the accuracy of the physician’s clinical 
judgment in initiating early treatment in bacterernic 
patients, the antimicrobial therapies started on the 
same day as blood sampling wwe recorded. We con- 
sidered that any use of intravenous antimicrobial 
therapy reflected the physician’s wish to treat a severe 
infection, potentially a bactereniic event. 
Blood sampling and assay 
Ten milliliters of blood was drawn with tubes 
containing ethylenediaminetetraacetic acid (EDTA) 
(Vacusysteni, Terumo Europe, Leuven, Belgium) con- 
comitantly with blood cultures. After centrifugation, 
plasma was stored at -40°C until assay. TNF-a and 
IL-6 were measured by an iniinunoradiometric assay 
(minimum detectable concentration: 15 pg/mL) and an 
iinmunoenzymetric assay (minimum detectable con- 
centration: 15 pg/mL), respectively (Medgenix, Fleurus, 
Belgium). CKP was measured using an innnuno- 
turbidimetric assay (Tina-quartt, Boehringer Mann- 
heim, Mannheini, Germany) (minimum detectable 
concentration: 0.6 mg/100 mL;. 
Statistical analysis 
Results are expressed as median (range). Coniparisons 
between groups were made using the Kruskal-Wallis 
test or ANOVA test following the results of Bartlett’s 
test for homogeneity of variance:. Statistical analysis was 
done on a personal computer using a program for 
statistics and epidemiology [9]. Relative operating 
characteristic (ROC) curves for CRP, 1L-6 and TNF- 
a were generated using each single result as the 
hypothetical cut-off of the system. The areas under the 
curves and standard errors associated with areas were 
calculated using the Wilcoxon statistic [10-121; area 
value is a relative measure of the performance charac- 
teristics of the test. The area value varies between 0.5 
(no apparent accuracy) and 1.0 (perfect accuracy) as the 
ROC curves moves towards the left and top boundaries 
of the ROC graph. 
RESULTS 
During the study period, 162 patients (103 males, 59 
females) fulfilling the inclusion criteria developed 1 66 
episodes of sepsis that justified blood cultures. Of  these 
episodes, 34 were associated with bacteremia, 69 were 
infections without bacteremia and 63 remained clinical 
episodes without documented infection. For simplicity, 
the term ‘patients’ will be used instead of episodes for 
the expression of the results. 
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The pathogens isolated from blood cultures were 
Enterobacteriaceae (13 isolates), Pseudomonas aeruginosa 
(2), Aeromonas hydrophila (l), Staphylococcus aureus (7), 
coagulase negative staphylococci (3), Moraxella catarrlzalis 
(l), enterococci (7), Streptococcus pneumoniae (2), group 
B Stveptococcus (l), and anaerobes (2). Five patients 
presented with polymicrobial bacteremia. The sources 
of infection are listed in Table 1. 
Among the infected patients, the mortality rate 
secondary to infection was greater in bacteremic 
patients than in non-bacteremic patients (p<0.01) 
(Table 2). In the same way, the initial SAPS score was 
significantly higher among bacteremic patients than 
Table 1 Sources of infection among patients with proven 
infection 
Hactereinic Non-bacteremic 
patients patients 
Sources of information (n=34) (p1=69) 
Respiratory tract 3 34 
Digestive tract 7 7 
Urinary tract 9 7 
Primary bactereinia 4 - 
IV catheter 3 - 
Endocarditis 1 ~ 
Others 7 21 
Table 2 Outcome and Simplified Acute Physiology Score 
(SAPS) in bacterernic patients, non-bacteremic patients, and 
patients without documented infection (median and range) 
Non- Non- 
Bactereinic bacteremic infected 
patients patients patients 
Outcome 
Survivors, no shock 30 68 56 
Survivors, shock 1 0 0 
Ileaths related to infection 3 1 0 
Deaths due to other causes 0 0 7 
SAPS 7 (0-23) 5 (0-14) 5 (0-21) 
among infected non-bacteremic patients (p=0.044) 
(Table 2). Among the non-infected patients, death was 
secondary to cerebral hemorrhage (4), acute myocardial 
infarction (2) and massive pulmonary emboli (1). 
Predictive value of cytokines and CRP levels for 
bacteremia 
TNF-CX and IL-6 plasma levels were significantly higher 
in bacteremic than in non-bacteremic infected patients 
(Table 3). IL-6 levels were also significantly higher 
among infected patients without bacteremia than in the 
non-infected patients, while no significant difference 
was noted in TNF-cx plasma levels between these two 
groups. CRP plasma levels were not significantly 
different among the three groups (Table 3). The areas 
under the ROC curves and their standard errors for 
IL-6, TNF-a  and CKP were 0.7020.06, 0.70k0.06 
and 0.53f0.06, respectively, for predicting bacteremia 
(Figure 1). IL-6 and TNF-a  discriminated better for 
bacteremia than did CRP. Indeed, no cut-off level with 
sufficient sensitivity and specificity was available for 
CRI? By contrast, 68% of the 34 bacteremic patients 
had IL-6 plasma levels above a cut-off point of 200 
pg/mL IL-6. The specificity of this cut-off point was 
65%. The same levels of sensitivity and specificity were 
achieved for TNF-a  plasma levels using a cut-off value 
of 25 pg/mL. 
Predictive value of cytokines and CRP levels for 
bacteremia among patients with signs of sepsis for less 
than 24 h 
We analyzed separately the 101 patients who developed 
signs of sepsis less than 24 h before blood cultures were 
drawn. Among these patients, 20 were bacteremic. The 
median values for IL-6, TNF-cx and CKP in the 
bacteremic patients were 678 pg/mL, 38 pg/mL and 
6.3 mg/dL, respectively (Figures 2-4). Median values 
of IL-6, TNF-a and CKP among infected and non- 
infected patients expressed in the same units (with p -  
values in comparison with bacteremic patients) were 
221, 15 and 7.9 (p-values: p<0.001, p<0.01, p=0.77), 
Table 3 Interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a) and C-reactive protein (CRP) plasma levels (median, range) 
in the three groups of patients 
Bactereiiiic patients Non-bacteremic patients Non-infected patients 
(11=34) (r1=69) (rr=63) 
IL-6 (pg/mL) 462 (15-50 850)a 189 (5-38 300)" 91 (0-13 750) 
TNF-E (pg/niL) 38 (Ck-2400)' 15 (0-240)' 15 (0-200) 
CRP (mg/dL) 8.8 (0-30.2)' 8.1 (0-34.4)' 5.8 (0-20.8) 
'p<0.01 between bacteremic patients and both other groups. 
"p<0.01 between non-bactereniic patients and non-infected patients. 
' No significant difference. 
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Figure 1 Interleulun-6, tumor necrosis factor-a and C-reactive protein relative operating characteristic (ROC) curves. 
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Figure 2 IL-6 plaqina levels of the three groups of patients with septic signs onset <24 h. 
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Figure 3 TNF-a plasma levels of the three groups of patients with septic signs onset <24 h. 
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Figure 4 CRP plasma levels of the three groups of patients with septic signs onset <24 h. 
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and 233, 15 and 5.8, respectively. The areas under 
the ROC curves (f SD) for IL-6, TNF-cx and CRP for 
prediction ofbacteremia were, respectively, 0.76 f 0.06, 
0.74kO.07 and 0.51 kO.08. 
IL-6 levels above 200 pg/inL were observed in 16 
of 20 (80%) bacteremic patients. However, 34 of 81 
(42%) patients devoid of bacteremia also had IL-6 
plasma levels above this cut-off value. The IL-6 (>200 
pg/mL) positive predictive value for bacteremia in this 
population was 32%. However, only 11 of the 34 non- 
bacteremic patients with high IL-6 levels had no proven 
infection requiring antimicrobial therapy. Thus 23 of 
34 (68%) of the ‘false-positive’ patients (i.e. wrongly 
considered as bacteremic patients) were also infected 
and needed antimicrobial therapy. 
Cytokine levels according to the type of pathogen in 
bacteremic patients 
In the 12 patients with Gram-positive bacteremia, and 
in the 17 patients with Grain-negative bacteremia, the 
median (range) IL-6 levels were 7410 (15-25 320) 
pg/mL and 488 (30-942) pg/niL (p=0.06), respec- 
tively. For TNF-a,  the corresponding plasma levels 
were 35 (<15-2400) pg/mL and 75 (<15-185) pg/mL 
(p=0.27), respectively. None of these differences was 
statistically significant. 
Predictive values of 11-6 and TNF-a for outcome 
IL-6 levels were significantly higher in the four patients 
with fatal outcomes related to infection than in the 162 
other patients. The mednn (range) values were 1205 
(431-12 000) pg/mL versus 127 (<15- 50 850) pg/mL 
( p  ~ 0 . 0 1 ) .  By contrast, TNF-a  levels were not signifi- 
cantly different in the two groups, the corresponding 
values being 105 (<15-2400) pg/mL versus 15 (<15- 
2100) pg/mL (p=0.28). 
Comparison of intention to treat with and without 11-6 
plasma level measurements 
The possible impact of IL-6 plasma level, if it had been 
available soon after blood sampling, on the antibiotic 
therapy prescribed by the attending physician was 
evaluated. Antimicrobial therapy was initiated in 21 of 
34 (62%) of the bacteremic patients. Combination of 
clinical signs and IL-6 blood mc:asurements would have 
allowed the physician to initiate early treatment in 28 
of 34 patients (82%1), i.e. in seven more patients than 
using clinical signs alone (Table 4). Overall, such a 
combination of either clinical findings or IL-6 plasma 
levels would have led to early treatment in 115/ 
164 patients (700/0), of whom 92 were infected (28 
bacteremic patients, 64 non-bactereniic patients) and 
23 were non-infected. Without the IL-6 plasma levels, 
89 patients were treated early (including 21 of 34 
bacteremic patients, 58 of 69 infected patients, and 10 
of 63 uninfected patients). Fin.ally, combining clinical 
signs and IL-6 plasma levels for decision of whether 
to treat, 13 patients more than using clinical findings 
alone would have been unnecessarily treated than if 
clinical findings alone were used, but 13 infected 
patients (including seven bacteremic patients) would 
have immediately received adequate therapy. 
DISCUSSION 
Bacteremia, particularly due to Gram-negative bacilli, 
results in an attributable mortality of about 25% even 
in cases of adequate antimicrobial therapy, and as high 
as 45% or more in cases of inappropriate treatment 
[1,2,13]. The need to initiate antimicrobial therapy 
as soon as possible is widely accepted. I t  has been 
shown that appropriate therapy early in the course of 
bacteremia decreases the subsequent incidence of shock 
and reduces the mortality [2,1.3-171. In these studies, 
only 60-80% of bacteremic patients received effective 
antimicrobial therapy within the day during which 
blood cultures were performed. O n  the other hand, 
the clinical judgment of the physician is relatively poor 
for distinguishing bacteremic from non-bacteremic 
patients at  the bedside. This could result in the absence 
of adequate treatment for some infected patients and 
prescription of unnecessary drugs for those who are not 
infected [18]. The attempts to predict bacteremia using 
simple clinical or chemical parameters [3-61 were often 
of little benefit. The association of fever, low systolic 
blood pressure and low platelet count had only 5% 
Table 4 Comparison of IL-6 measurement with the empirical prescription of antibiotics a m o n g  the three groups of 
patients. 
IL-6 levels Antimicrobial Bacteremic patients Infected patients No infection 
(pg/mL) therapy (34) (69) (63) 
>200 Treated 16 26 1 
>200 Not treated 7 6 13 
<200 Treated 5 32 9 
< 200 Not treated 6 5 4 0 
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sensitivity in detection of bacteremia [3]. Five para- 
meters (serum albumin, chills, functional status, renal 
failure and clinical suspicion of urinary tract infection) 
included in a logistic model were significantly and 
independently correlated with bacteremia but these 
data allowed separation of the patients only into 
groups with ‘low’, ‘medium’ and ‘high’ prevalence of 
bacteremia [4]. C R P  is one of the acute phase proteins 
with a shorter half-life, and is characterized by its 
rapid increase during inflammation or infection [19]. 
Although CRP provides useful information, it has little 
value as a differential diagnostic test in the acute clinical 
situation [20]. Our study confirms that C R P  does not 
have sufficient predictive value to detect bacteremia 
among patients presenting signs of sepsis. TNF-cx and 
cortisol plasma levels were also used in a retrospective 
study, without success, to discriminate bacteremic from 
non-bacteremic patients [21]. 
IL-6 has been extensively studied in septic 
shock. Its value as a predictive factor for diagnosis of 
bacteremia or other infection is poorly known but it 
was used with success in a recent report concerning 
neutropenic patients [22]. In a previous study [23], we 
showed that a high IL-6 plasma level is an exquisitely 
sensitive and early marker of infection in the peculiar 
population of cirrhotic patients, where differences in 
IL-6 plasma levels are exacerbated by decreased meta- 
bolism and increased production. In these patients, 
IL-6 plasma levels during uncomplicated infection 
were as high as those obtained in non-cirrhotic patients 
presenting with septic shock. For this reason, cirrhotic 
patients were excluded from this study. 
The sensitivity of IL-6 plasma levels >200 pg/mL 
for detecting bacteremia reaches 66% or 80%, depend- 
ing on the delay between the onset of signs of sepsis 
and blood sampling for cytokine assay. Despite the low 
positive predictive value (33%) of such levels of IL-6, 
starting antimicrobial therapy according to high plasma 
levels would not be responsible for extensive over- 
treatment if it is kept in mind that 75% of the ‘false 
positives’ (i.e. non-bacteremic patients with high IL-6 
plasma levels) are infected patients who also need anti- 
microbial therapy. Interestingly, the clinical sensitivity 
for detecting bactereniia is probably overestimated 
in this study, because we have considered that any 
initiation of intravenous antimicrobial therapy reflects 
clinical suspicion of bacteremia and not only a localized 
infectious process. Despite this fact, IL-6 plasma 
level was more sensitive than the ‘clinical sensitivity’. 
Moreover, the choice of antimicrobial therapy might 
have been more appropriate if the attending physician 
had had an immediate diagnosis of bacteremia. Indeed, 
among the seven patients who had IL-6 levels 
above 200 pg/iiiL, but who did not receive adequate 
antimicrobial therapy for such a clinical condition, 
four patients were given inadequate treatment such as 
noriloxacin, or low doses of other oral antimicrobial 
drugs. A recent study found comparable results among 
emergency department patients, although the authors 
emphasize a high predictive value with a low sensitivity 
for detection of bacteremia (44% for an IL-6 cut-off 
value of 2 ng/mL) [24]. 
From the relationship between delay in starting 
adequate antimicrobial therapy and clinical outcome, a 
role for IL-6 plasma levels for detecting bacteremia 
among patients with signs of sepsis is suggested by the 
present study. New developments in cytokine measure- 
ment will allow us in the near future to perform 
cytokine assays quickly to produce results before 
microbiological results are available. Although IL-6 
per se is not much more efficient than clinical judgment 
in discriminating bacteremic from non-bacteremic 
patients, the association of both could greatly improve 
the detection of bacteremic patients and allow them to 
be treated promptly. The effect of such an approach on 
morbidity and mortality remains to be determined on 
a prospective basis. 
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